Tengfei Pan
Ministry of Education of the People's Republic of China(CN)Harbin Medical University(CN)Ministry of Education(KR)Air Force Medical University(CN)
Publications by Year
Research Areas
Liver Disease Diagnosis and Treatment, Prostate Cancer Treatment and Research, PI3K/AKT/mTOR signaling in cancer, Blood Pressure and Hypertension Studies, Mitochondrial Function and Pathology
Most-Cited Works
- → mTOR regulate EMT through RhoA and Rac1 pathway in prostate cancer(2014)57 cited
- → Kanglexin, a new anthraquinone compound, attenuates lipid accumulation by activating the AMPK/SREBP-2/PCSK9/LDLR signalling pathway(2020)50 cited
- → Anti‐b diminishes hyperlipidaemia and hepatic steatosis in hamsters and mice by suppressing the mTOR/PPARγ and mTOR/SREBP1 signalling pathways(2024)11 cited
- → A novel deacetylase inhibitor KLX suppresses liver fibrosis by deacetylating PPARγ through promoting ubiquitination-mediated HDAC1 degradation(2025)5 cited
- → Organelle interplay in cardiovascular diseases: Mechanisms, pathogenesis, and therapeutic perspectives(2025)2 cited
- → Prevention and control measures of the major cold-region diseases (hypertension) in China(2021)2 cited